Invokana 100 Mg Tablets

  • Product Name : Invokana 100 Mg Tablets
  • Category : Tablet
  • Manufacturer Name : Janssen
  • Trade Name : Invokana 100 mg
  • Available Dosage : 100 mg
  • Packing :
  • Pack Insert/Leaflet : 10 Tablet
  • Ingredients : Canagliflozin
  • Formulation : Tablet
  • Therapeutic use : Type 2 Diabetes Mellitus
  • Production Capacity : 100000

Description:-

Unveiling Invokana 100 mg Tablet, a versatile medication designed for standalone use or in combination with other drugs to effectively manage type 2 diabetes mellitus. Engineered to regulate elevated blood sugar levels associated with diabetes, this medication not only reduces the risk of serious diabetes complications but also acts as a preventive measure against heart disease.


Invokana 100 mg Tablet offers flexibility in administration, allowing you to take it with or without food at any time of the day. However, maintaining a consistent daily schedule is recommended. Your doctor will determine the appropriate dosage, and it is imperative not to discontinue the medication without consulting your healthcare provider. Abruptly stopping Invokana 100 mg Tablet may lead to an increase in blood sugar levels, putting you at risk of serious complications such as kidney damage and blindness. This medication is an integral part of a comprehensive treatment program that should encompass a healthy diet, regular exercise, and weight reduction as advised by your doctor.


Medical Uses:


Invokana 100 mg Tablet for Type 2 Diabetes Mellitus


Unlocking the Benefits:


Invokana 100 mg Tablet is a powerful medication that aids in controlling high blood glucose levels by facilitating the removal of excess glucose through urine. Effectively managing blood glucose levels is crucial for reducing the risk of serious diabetes complications, including kidney damage, eye issues, nerve problems, and limb loss. Moreover, this medication significantly lowers the risk of cardiovascular disease-related mortality in individuals with type 2 diabetes and existing cardiovascular conditions.